Press release
Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for Biodegradable Alternatives by 2031
Bio-Based Molecule
The Bio-Based Molecule Market is spearheaded by leading industrial biotech firms, including Arkema, Covestro, and Borregaard, backed by global engineering groups like GEA Group and DE Smet Engineers. AVA Biochem, Jiangmen Xinshuo, and NTIC excel in fine chemicals and niche bio-molecule offerings, while Gevo advances biofuel-related platform chemicals. These companies are forging ahead via technology advancement, sustainable feedstock sourcing.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/bio-based-molecule-market?jd
Bio-Based Molecule Market M&A & Strategic Collaborations
1. Roquette Acquires IFF Pharma Solutions
Roquette's US$2.85 billion deal adds IFF's pharmaceutical excipient assets, reinforcing its footprint in bio-based chemical manufacturing.
2. GenoFAB Joins US Bio-Manufacturing Institute
GenoFAB became part of the BioMADE consortium to accelerate bio-industrial molecule innovation via public-private collaboration.
3. Bloom Biorenewables Raises USD 15 M Funding
The Switzerland-based startup secured investment to scale lignin- and cellulose-based specialty bio-molecules in cosmetics and materials.
These recent developments emphasize investments in production expansion, strategic licensing, and technology cluster building, underlining how capital partnerships and M&A fuel innovation and market readiness, as per our analysis.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bio-based-molecule-market?jd
Key Growth Drivers & Emerging Opportunities in the Bio-Based Molecule Market
• Technology advances in fermentation, enzymatic processes, and synthetic biology are improving production efficiency.
• Rising consumer and regulatory demand for sustainable alternatives in packaging, textiles, and personal care chemicals.
• Government incentives and green policies, such as the European Green Deal and USDA BioPreferred, support industry adoption.
• Biomaterials funding rebounded with US$392 million raised in Q1 2025, signaling investor interest in specialty bio-material startups.
• Expansion in high-value niche markets, such as bio-based solvents, SAPs, and cosmetic-grade molecules, offers premium product opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bio-based-molecule-market?jd
Regional Market Drivers for the Bio-Based Molecule Market
North America (35.5% share): Led by regulatory support, R&D incentives, and growing adoption of sustainable chemicals.
Europe: Driven by the European Green Deal, stricter plastic regulations, and strong investment in biorefineries.
Asia Pacific: Rapid industrialization, environmental regulations, and expansion of biotech hubs in China and India are key growth factors.
Latin America & MEA: Emerging demand in agri-chemicals and bio-packaging, supported by global sustainability initiatives.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bio-Based Molecule Market Driven by Sustainability Goals and Rising Demand for Biodegradable Alternatives by 2031 here
News-ID: 4104954 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Human Immunodeficiency Virus Type 1 Treatment Market Expands with Breakthrough H …
"Global Human Immunodeficiency Virus Type-1 (HIV-1) Treatment Market reached US$39,670.14 million in 2023 and is expected to reach US$62,752.56 million by 2031, growing at a CAGR of 5.9% during the forecast period 2024-2031," according to DataM Intelligence.
The HIV 1 treatment market is dominated by established pharmaceutical leaders such as Gilead Sciences, ViiV Healthcare, Janssen, Viatris, and Merck, which offer a wide range of antiretroviral therapies (ARTs), including fixed-dose combinations and…
Veterinary Surgical Sutures Market Innovation Accelerates with Biodegradable Mat …
"The Global Veterinary Surgical Sutures Market reached US$178.6 million in 2023 and is expected to reach US$284.7 million by 2031, growing with a CAGR of 6% during the forecast period 2024-2031," according to DataM Intelligence.
The Veterinary Surgical Sutures market is led by reputable medical device manufacturers, including B. Braun, Medtronic, CP Medical, Vitrex Medical, and Air-Tite Products, all offering a wide range of suture types for animal surgery. Johnson &…
Epidural Abscess Treatment Market Forecast 2024-2031: Early Detection Tools and …
"The epidural abscess treatment market is projected to grow from $41.11 billion in 2024 to $56.78 billion by 2029, registering a strong CAGR of 6.6% - 7.1%," according to DataM Intelligence.
The Epidural Abscess Treatment Market features a diverse mix of global pharmaceutical and device leaders. Alembic Ltd, Sun Pharmaceutical, Sandoz, and Novartis contribute with broad-spectrum antibiotic portfolios and spinal infection therapies. Device and diagnostic sophistication come from Eli Lilly,…
Pemphigus Vulgaris Treatment Market Expands with Novel Anti-CD20 Antibody Approv …
"The Global Pemphigus Vulgaris Treatment Market reached US$473.4 million in 2023 and is expected to reach US$896.1 million by 2031, growing with a CAGR of 8.3% during the forecast period 2024-2031," according to DataM Intelligence.
The Pemphigus Vulgaris treatment market features a strong lineup of pharmaceutical leaders and emerging biotech innovators. Roche, Pfizer, Novartis, Sanofi, AbbVie, and AstraZeneca dominate with their biologic and immunomodulatory portfolios. Teva, GSK, and Zydus Group bolster…
More Releases for Molecule
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that…
Sterile Injectables Global Market 2019 - Analysis By Molecule Type, Drug Type, I …
Press Release – 18 Jan 2019
Research and Development News --
. .
Latest Update "Global Sterile Injectables Market - Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders - Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)" with Industries Survey |…
Fast FDA approvals and Growth in Small Molecule Pipeline is Fuelling the Revenue …
A FMI study titled “Small Mole API Market” has highlighted that small molecule APIs continue to dominate the pharmaceutical market with fast U.S. FDA approvals for small molecule APIs in 2017. Small molecules are chemical substances composed of two or more atoms with molecular weight of less than 900 Dalton. In this report, the small molecule API segment is further categorized into standard API and high potency APIs. The U.S.…
Nanoscale Virus Trap Molecule Market
Advancement into scientific research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evolution, things are becoming miniature in size, be it electronic chips, medical devices, or pharmaceutical drug. However, miniaturization, also referred as nanotechnology, doesn’t compromise on the product quality and effectiveness. Instead there is improved quality and features delivered via this technology.
Nanotechnology has a real potential to revolutionize…
Small Molecule Cancer Drug Clinical Pipeline Insight
Oncologists are continuously looking for better therapeutic options to effectively cure and prevent different types of malignancies. Conventionally, surgery and radiation were widely used for cancer treatment but they have modest benefits. Presently, global market consists of several options for cancer treatment which belongs to various classes of molecules. Their utilization in therapeutic regime depends on the patient’s medical condition, pharmacological and financial benefits offered by them during treatment. Out…
Nanoscale Virus Trap Molecule Market
Advancement into scientific research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evolution, things are becoming miniature in size, be it electronic chips, medical devices, or pharmaceutical drug. However, miniaturization, also referred as nanotechnology, doesn’t compromise on the product quality and effectiveness. Instead there is improved quality and features delivered via this technology.
Nanotechnology has a real potential to revolutionize…
